Meng F - Search Results

1

Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer.

Yin M, Li C, Li X, Lou G, Miao B, Liu X, Meng F, Zhang H, Chen X, Sun M, Ling Q, Zhou R. Yin M, et al. Among authors: meng f. J Surg Oncol. 2011 Jul 1;104(1):29-36. doi: 10.1002/jso.21912. Epub 2011 Mar 17. J Surg Oncol. 2011. PMID: 21416470

2

LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis.

Yin M, Xu Y, Lou G, Hou Y, Meng F, Zhang H, Li C, Zhou R. Yin M, et al. Among authors: meng f. Int J Cancer. 2011 Aug 1;129(3):629-35. doi: 10.1002/ijc.25689. Epub 2010 Nov 28. Int J Cancer. 2011. PMID: 20857494

3

Overexpression of LAPTM4B-35 in cervical carcinoma: a clinicopathologic study.

Meng F, Luo C, Hu Y, Yin M, Lin M, Lou G, Zhou R. Meng F, et al. Int J Gynecol Pathol. 2010 Nov;29(6):587-93. doi: 10.1097/PGP.0b013e3181e0898e. Int J Gynecol Pathol. 2010. PMID: 20881850

4

LAPTM4B-35 overexpression is an independent prognostic marker in endometrial carcinoma.

Meng FL, Yin MZ, Song HT, Yang H, Lou G, Zhou RL. Meng FL, et al. Int J Gynecol Cancer. 2010 Jul;20(5):745-50. doi: 10.1111/IGC.0b013e3181e02f90. Int J Gynecol Cancer. 2010. PMID: 20966643

5

Clinical significance of astrocyte elevated gene-1 expression in human epithelial ovarian carcinoma.

Meng F, Luo C, Ma L, Hu Y, Lou G. Meng F, et al. Int J Gynecol Pathol. 2011 Mar;30(2):145-50. doi: 10.1097/PGP.0b013e3181ffd2f7. Int J Gynecol Pathol. 2011. PMID: 21293286

6

The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.

Yin M, Zhao F, Lou G, Zhang H, Sun M, Li C, Hou Y, Li X, Meng F, Chen X. Yin M, et al. Among authors: meng f. Int J Gynecol Cancer. 2011 Jan;21(1):92-9. doi: 10.1111/IGC.0b013e3181fe8b6e. Int J Gynecol Cancer. 2011. PMID: 21330834

7

Correlation of LAPTM4B polymorphisms with cervical carcinoma.

Meng F, Song H, Luo C, Yin M, Xu Y, Liu H, Zhou R, Lou G. Meng F, et al. Cancer. 2011 Jun 15;117(12):2652-8. doi: 10.1002/cncr.25833. Epub 2011 Jan 10. Cancer. 2011. PMID: 21656743 Free article.

8

LAPTM4B overexpression is a novel independent prognostic marker for metastatic ovarian tumors.

Yin M, Lou C, Zhang W, Meng F, Zhang H, Ning X, Zhou R, Dong X, Lou G. Yin M, et al. Among authors: meng f. Int J Gynecol Cancer. 2012 Jan;22(1):54-62. doi: 10.1097/IGC.0b013e318234f9ac. Int J Gynecol Cancer. 2012. PMID: 22193644

9

LAPTM4B polymorphisms is associated with ovarian cancer susceptibility and its prognosis.

Xu Y, Liu Y, Zhou R, Meng F, Gao Y, Yang S, Li X, Yang M, Lou G. Xu Y, et al. Among authors: meng f. Jpn J Clin Oncol. 2012 May;42(5):413-9. doi: 10.1093/jjco/hys026. Epub 2012 Mar 12. Jpn J Clin Oncol. 2012. PMID: 22412199

10

Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.

Yang S, Li H, Liu Y, Ning X, Meng F, Xiao M, Wang D, Lou G, Zhang Y. Yang S, et al. Among authors: meng f. Med Oncol. 2013 Mar;30(1):324. doi: 10.1007/s12032-012-0324-7. Epub 2012 Dec 18. Med Oncol. 2013. PMID: 23254963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,101 results

Search Page

Filters